Marialuisa Sensi
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Multistep tumor genetic evolution and changes in immunogenicity trigger immune-mediated disease eradication in stage IV melanoma: lessons from a single case.
Journal: Journal for immunotherapy of cancer
Published: November 30, 2023
Genomic and transcriptomic analyses of thyroid cancers identify DICER1 somatic mutations in adult follicular-patterned RAS-like tumors.
Journal: Frontiers in endocrinology
Published: July 26, 2023
A Cross-Comparison of High-Throughput Platforms for Circulating MicroRNA Quantification, Agreement in Risk Classification, and Biomarker Discovery in Non-Small Cell Lung Cancer.
Journal: Frontiers in oncology
Published: April 02, 2022
Genetic Layout of Melanoma Lesions Is Associated with BRAF/MEK-Targeted Therapy Resistance and Transcriptional Profiles.
Journal: The Journal of investigative dermatology
Published: December 15, 2021
Circulating miRNAs as Novel Non-Invasive Biomarkers to Aid the Early Diagnosis of Suspicious Breast Lesions for Which Biopsy Is Recommended.
Journal: Cancers
Published: July 16, 2021
miR-146a-5p impairs melanoma resistance to kinase inhibitors by targeting COX2 and regulating NFkB-mediated inflammatory mediators.
Journal: Cell communication and signaling : CCS
Published: February 25, 2020
The genomics of desmoplastic small round cell tumor reveals the deregulation of genes related to DNA damage response, epithelial-mesenchymal transition, and immune response.
Journal: Cancer communications (London, England)
Published: March 27, 2018
Axl in ovarian cancer: a step forward for clinical breakthrough?
Journal: Oncotarget
Published: November 24, 2016
Novel Axl-driven signaling pathway and molecular signature characterize high-grade ovarian cancer patients with poor clinical outcome.
Journal: Oncotarget
Published: June 12, 2015
Last Updated: 09/26/2026